{"name":"GlaxoSmithKline","permalink":"glaxosmithkline","crunchbase_url":"http://www.crunchbase.com/company/glaxosmithkline","homepage_url":"http://www.gsk.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"healthcare, pharmaceuticals, uk, aids, hiv, malaria, medical-research","alias_list":"GSK","email_address":"","phone_number":"+44 (0)20 8047 5000 ","description":"HIV, TB pharmaceuticals","created_at":"Wed May 21 22:03:45 UTC 2008","updated_at":"Thu Dec 01 07:45:00 UTC 2011","overview":"<p>GSK is a UK-based pharmaceutical and healthcare company focusing on research to develop and distribute treatments for HIV/AIDS, TB, and malaria.  They also distribute some OTC products. </p>","image":{"available_sizes":[[[150,51],"assets/images/resized/0005/1020/51020v1-max-150x150.png"],[[158,54],"assets/images/resized/0005/1020/51020v1-max-250x250.png"],[[158,54],"assets/images/resized/0005/1020/51020v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":true,"title":"Chief Medical Officer, Senior VP for Clinical Development","person":{"first_name":"Peter","last_name":"G. Traber","permalink":"peter-g-traber","image":null}},{"is_past":true,"title":"Senior VP, Global Clinical Pharmacology, New Product Development & Drug Discovery","person":{"first_name":"Marc","last_name":"Rubin","permalink":"marc-rubin","image":null}},{"is_past":true,"title":"Statistician","person":{"first_name":"Sweta","last_name":"Sharma","permalink":"sweta-sharma","image":{"available_sizes":[[[150,148],"assets/images/resized/0004/6858/46858v2-max-150x150.jpg"],[[250,248],"assets/images/resized/0004/6858/46858v2-max-250x250.jpg"],[[450,446],"assets/images/resized/0004/6858/46858v2-max-450x450.jpg"]],"attribution":""}}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":24500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Chroma Therapeutics","permalink":"chroma-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],[[257,90],"assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/genmab-wins-23m-blockbuster-cancer-approval/2009-10-27?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Genmab wins $23M on blockbuster cancer approval","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":1,"company":{"name":"Genmab","permalink":"genmab","image":{"available_sizes":[[[150,44],"assets/images/resized/0006/3972/63972v1-max-150x150.png"],[[250,73],"assets/images/resized/0006/3972/63972v1-max-250x250.png"],[[265,78],"assets/images/resized/0006/3972/63972v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://files.shareholder.com/downloads/THERA/1081492124x0x423203/75b3d5f1-c9fb-417f-8195-fcc7980964eb/GSK_to_Increase_Its_Shareholding_in_Theravance_Final_Press_Release_2010Nov29.pdf","source_description":"GlaxoSmithKline to Increase Its Shareholding in Theravance","raised_amount":129375000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":29,"company":{"name":"Theravance","permalink":"theravance","image":{"available_sizes":[[[150,60],"assets/images/resized/0011/2217/112217v1-max-150x150.png"],[[152,61],"assets/images/resized/0011/2217/112217v1-max-250x250.png"],[[152,61],"assets/images/resized/0011/2217/112217v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/06/20/daily1-Concert-Pharmaceuticals-lands-4M-milestone-pay.html","source_description":"Concert Pharmaceuticals lands $4M milestone pay","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":20,"company":{"name":"Concert Pharmaceuticals","permalink":"concert-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/5452/45452v1-max-150x150.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-250x250.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.epizyme.com/news-events/press-release_2011-11-14.asp","source_description":" Epizyme Achieves $4 Million in Pre-Clinical Milestone Payments in GlaxoSmithKline Alliance to Discover and Develop Novel HMT Therapeutics ","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":14,"company":{"name":"Epizyme","permalink":"epizyme","image":{"available_sizes":[[[150,74],"assets/images/resized/0006/1969/61969v1-max-150x150.jpg"],[[250,124],"assets/images/resized/0006/1969/61969v1-max-250x250.jpg"],[[450,224],"assets/images/resized/0006/1969/61969v1-max-450x450.jpg"]],"attribution":null}}}}],"acquisition":null,"acquisitions":[{"price_amount":720000000,"price_currency_code":"USD","term_code":"cash","source_url":"http://phx.corporate-ir.net/phoenix.zhtml?c=185399&p=irol-newsArticle&ID=1133582&highlight=","source_description":"GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development","acquired_year":2008,"acquired_month":4,"acquired_day":22,"company":{"name":"Sirtris Pharmaceuticals","permalink":"sirtris-pharmaceuticals","image":{"available_sizes":[[[150,65],"assets/images/resized/0001/9070/19070v1-max-150x150.jpg"],[[230,100],"assets/images/resized/0001/9070/19070v1-max-250x250.jpg"],[[230,100],"assets/images/resized/0001/9070/19070v1-max-450x450.jpg"]],"attribution":null}}},{"price_amount":3600000000,"price_currency_code":"USD","term_code":"cash_and_stock","source_url":"http://www.forbes.com/2009/04/20/gsk-stiefel-deal-markets-equity-pharmaceuticals-update.html","source_description":"Glaxo Bags Stiefel","acquired_year":2009,"acquired_month":4,"acquired_day":20,"company":{"name":"Stiefel","permalink":"stiefel","image":{"available_sizes":[[[150,76],"assets/images/resized/0005/1021/51021v1-max-150x150.png"],[[162,83],"assets/images/resized/0005/1021/51021v1-max-250x250.png"],[[162,83],"assets/images/resized/0005/1021/51021v1-max-450x450.png"]],"attribution":null}}},{"price_amount":57000000,"price_currency_code":"USD","term_code":"cash","source_url":"http://www.biojobblog.com/2009/01/articles/biojobbuzz/more-layoffs-gsk-completes-purchase-of-genelabs-technologies-inc/","source_description":"More Layoffs: GSK Completes Purchase of Genelabs Technologies, Inc.","acquired_year":2008,"acquired_month":11,"acquired_day":null,"company":{"name":"Genelabs Technologies","permalink":"genelabs-technologies","image":{"available_sizes":[[[150,39],"assets/images/resized/0005/9344/59344v1-max-150x150.jpg"],[[162,43],"assets/images/resized/0005/9344/59344v1-max-250x250.jpg"],[[162,43],"assets/images/resized/0005/9344/59344v1-max-450x450.jpg"]],"attribution":null}}}],"offices":[],"milestones":[],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":null,"pub_month":null,"pub_day":null,"stock_symbol":"GSK"},"video_embeds":[],"screenshots":[],"external_links":[]}